Peter Murphy
Corporate Officer/Principal chez TELA BIO, INC.
Fortune : 272 891 $ au 31/03/2024
Profil
Peter Murphy is currently the Chief Commercial Officer at TELA Bio, Inc. Prior to this, he worked at Pacira Pharmaceuticals, Inc. (California) as the Vice President-Sales from 2017 to 2020.
He completed his undergraduate degree at Gettysburg College.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
TELA BIO, INC.
0,20% | 31/03/2024 | 48 129 ( 0,20% ) | 272 891 $ | 31/03/2024 |
Postes actifs de Peter Murphy
Sociétés | Poste | Début |
---|---|---|
TELA BIO, INC. | Corporate Officer/Principal | 29/01/2020 |
Anciens postes connus de Peter Murphy
Sociétés | Poste | Fin |
---|---|---|
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Sales & Marketing | 01/01/2020 |
Formation de Peter Murphy
Gettysburg College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
TELA BIO, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Health Technology |